RGLS-4326 | Interleukin Related interleukin-related.com

Product Name :
RGLS-4326

Search keywords :
RGLS4326

drugId :
null

Target Vo:
MicroRNA-17

Target Vo Short Name :
MIR17

Moa_Name:
MicroRNA-17 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Regulus Therapeutics

Active Company_Name :
Regulus Therapeutics

Active Indication_Name:
Polycystic Kidney, Autosomal Dominant

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
A-RAF Rabbit mAb medchemexpress
CD19 Rabbit mAb Purity & Documentation
Pyruvate Dehydrogenase E1 alpha Antibody (YA681): Pyruvate Dehydrogenase E1 alpha Antibody (YA681) is a non-conjugated and Mouse origined monoclonal antibody about 43 kDa, targeting to Pyruvate Dehydrogenase E1 alpha (3H2). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts